Back
Regenxbio Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
17
RGNX
Regenxbio
Last Price:
9.74
Seasonality Move:
5.73%
Sell
22
ALNY
Alnylam Pharmaceuticals
Last Price:
267.99
Seasonality Move:
5.05%
Sell
17
Regenxbio (RGNX)
is a Sell
Is Regenxbio a Buy, Sell or Hold?
- The current Regenxbio [RGNX] share price is $9.72. The Score for RGNX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- RGNX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $267.99. The Score for ALNY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $267.99
The current trend is moderately bearish and ALNY is experiencing slight buying pressure.
RGNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 32.61 | Sell |
| Chaikin Money Flow: | 250564 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.45 - 12.43) | Sell |
| Bollinger Bands (100): | (11.12 - 14.14) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.35 | Buy |
| Relative Strength Index (14 RSI): | 49.06 | Sell |
| Chaikin Money Flow: | 30222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (257.4 - 275.32) | Buy |
| Bollinger Bands (100): | (181.37 - 279.87) | Buy |
RGNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.25 | Sell |
| 20-day SMA: | 11.41 | Sell |
| 50-day SMA: | 11.98 | Sell |
| 200-day SMA: | 15.17 | Sell |
| 8-day EMA: | 10.25 | Sell |
| 20-day EMA: | 11 | Sell |
| 50-day EMA: | 11.8 | Sell |
| 200-day EMA: | 14.54 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 272.8 | Sell |
| 20-day SMA: | 269.57 | Sell |
| 50-day SMA: | 266.04 | Buy |
| 200-day SMA: | 196.91 | Buy |
| 8-day EMA: | 271.45 | Sell |
| 20-day EMA: | 270.16 | Sell |
| 50-day EMA: | 260.28 | Buy |
| 200-day EMA: | 214.75 | Buy |
Regenxbio Earnings Growth & RGNX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $3.83 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
Regenxbio Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||